Inventor · disambiguated record
Barbara Chen
Also filed as: CHEN BARBARA · CHEN BARBARA B · CHEN BARBARA BAOSHENG
32 granted patents·10 pending applications·683 citations·filing 1992–2007
97Inventor score
Top patents by PatentIndex Score
42 records- 0196US7205329B2Modulators of CRTH2 activityMICROBIA INC·Filed 2005·Granted Apr 17, 2007·117 cites·17 claims
- 0292US5773646AMeta-substituted phenylene derivativesSEARLE & CO·Filed 1997·Granted Jun 30, 1998·136 cites·30 claims
- 0390US5723492ALTA4 hydrolase inhibitor pharmaceutical compositions and methods of useSEARLE & CO·Filed 1995·Granted Mar 3, 1998·83 cites·16 claims
- 0487US5719306ALTA4 hydrolase inhibitorsSEARLE & CO·Filed 1995·Granted Feb 17, 1998·65 cites·9 claims
- 0583US5585492ALTA4 Hydrolase inhibitorsSEARLE & CO·Filed 1994·Granted Dec 17, 1996·43 cites·18 claims
- 0681US6531494B1Gem-substituted αvβ3 antagonistsPHARMACIA CORP·Filed 2001·Granted Mar 11, 2003·10 cites·15 claims
- 0780US5952381APara-substituted phenylene derivativesSEARLE & CO·Filed 1997·Granted Sep 14, 1999·44 cites·28 claims
- 0877US5852210ACinnamic acid derivativesSEARLE & CO·Filed 1997·Granted Dec 22, 1998·45 cites·32 claims
- 0975US7119098B2Heteroarylakanoic acids as intergrin receptor antagonistsPHARMACIA CORP·Filed 2001·Granted Oct 10, 2006·8 cites·20 claims
- 1075US6921767B2Cycloalkyl alkanoic acids as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2002·Granted Jul 26, 2005·9 cites·2 claims
- 1174US6933304B2Heteroarylalkanoic acids as integrin receptor antagonistsPHARMACIA CORP·Filed 2001·Granted Aug 23, 2005·8 cites·22 claims
- 1272US6506876B1LTA4 hydrolase inhibitor pharmaceutical compositions and methods of useSEARLE & CO·Filed 1994·Granted Jan 14, 2003·20 cites·1 claims
- 1371US7960544B2Useful indole compoundsIRONWOOD PHARMACEUTICALS INC·Filed 2006·Granted Jun 14, 2011·1 cites·34 claims
- 1468US6949578B2Cycloalkyl alkanoic acids as integrin receptor antagonistsPHARMACIA CORP·Filed 2004·Granted Sep 27, 2005·3 cites·27 claims
- 1568US6900232B2Cycloalkyl alkanoic acids as integrin receptor antagonistsPHARMACIA CORP·Filed 2001·Granted May 31, 2005·3 cites·65 claims
- 1668US5773644ACyclopropyl alkanoic acid derivativesSEARLE & CO·Filed 1997·Granted Jun 30, 1998·28 cites·31 claims
- 1762US5246969ADi-propargyl-containing aryl/alkylsulfonyl-terminated alanine amino-diol compounds for treatment of hypertensionSEARLE & CO·Filed 1992·Granted Sep 21, 1993·6 cites·25 claims
- 1858US7115596B2Thiazole compounds as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2003·Granted Oct 3, 2006·1 cites·6 claims
- 1956US6110944ALTA4, hydrolase inhibitorsSEARLE & CO·Filed 1997·Granted Aug 29, 2000·12 cites·4 claims
- 2055US5312838Aβ-alanineamide aryl/alkylsulfide/sulfonyl-terminated amino-diol compounds for treatment of hypertensionSEARLE & CO·Filed 1992·Granted May 17, 1994·5 cites·30 claims
- 2155US2007161698A1Modulators of CRTH2 ActivityMICROBIA INC·Filed 2007·Application pending·0 cites
- 2254US5268391APropargyl-terminated cycloalkylalkyl-P2-site substituted aryl/alkylsulfonyl-terminated alanine amino-diol compounds for treatment of hypertensionC D SEARLE & CO·Filed 1992·Granted Dec 7, 1993·5 cites·25 claims
- 2352US6251944B1Para-substituted phenylene derivativesSEARLE & CO·Filed 1999·Granted Jun 26, 2001·9 cites·30 claims
- 2452US5432201AAlkylaminoalkyl-sulfonyl-terminated β-alanineamide amino-diol compounds for treatment of hypertensionSEARLE & CO·Filed 1993·Granted Jul 11, 1995·3 cites·30 claims
- 2547US6403648B2Alkylaminoalkyl-sulfonyl-terminated β-alanineamide amino-diol compounds for treatment of hypertensionSEARLE & CO·Filed 2001·Granted Jun 11, 2002·0 cites·13 claims
- 2647US5314920AEthynyl-alanine aryl/alkylsulfonyl-terminated amino-diol compounds for treatment of hypertensionSEARLE & CO·Filed 1992·Granted May 24, 1994·3 cites·25 claims
- 2746US5756549AAlkylaminoalkyl-terminated sulfide/sulfonyl-containing cycloalkyl-alanine amino-diol compounds for treatment of hypertensionSEARLE & CO·Filed 1996·Granted May 26, 1998·2 cites·8 claims
- 2846US2004043994A1Gem-substituted alpha v beta 3 antagonistsFiled 2003·Application pending·0 cites
- 2944US2005032747A1COX-2 and FAAH inhibitorsFiled 2004·Application pending·0 cites
- 3044US2005004200A1Pyrazole compounds as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3144US2007203209A1Useful indole compoundsBARTOLINI WILMIN·Filed 2006·Application pending·0 cites
- 3243US2005043344A1Heteroarylalkanoic acids as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3342US2005234244A1Synthesis of COX-2 and FAAH inhibitorsBARTOLINI WILMIN·Filed 2004·Application pending·0 cites
- 3441US5925654ALTA4 , hydrolase inhibitorsSEARLE & CO·Filed 1997·Granted Jul 20, 1999·3 cites·9 claims
- 3540US5968984AAlkylaminoalkyl-sulfonyl-terminated β-alanineamide amino-diol compounds for treatment of hypertensionSEARLE & CO·Filed 1997·Granted Oct 19, 1999·1 cites·8 claims
- 3640US5416119AAlkylaminoalkyl-terminated sulfide/sulfonyl-containing cycloalkyl-alanine amino-diol compounds for treatment of hypertensionSEARLE & CO·Filed 1993·Granted May 16, 1995·5 cites·17 claims
- 3740US2007166336A1Stable and palatable oral liquid sumatriptan compositionsDELMARRE DAVID·Filed 2006·Application pending·0 cites
- 3838US6265433B1LTA4 hydrolase inhibitorsSEARLE & CO·Filed 1999·Granted Jul 24, 2001·2 cites·29 claims
- 3938US2004043988A1Cycloalkyl alkanoic acids as intergrin receptor antagonistsFiled 2001·Application pending·0 cites
- 4038US2005234030A1Modulators of CRTH2, COX-2 and FAAHBARTOLINI WILMIN·Filed 2005·Application pending·0 cites
- 4136US5488066AAlkylaminoalkyl-terminated sulfide/sulfonyl-containing cycloalkyl-alanine amino-diol compounds for treatment of hypertensionSEARLE & CO·Filed 1995·Granted Jan 30, 1996·2 cites·8 claims
- 4231US5317039ACyclopropyl-alanine aryl/alkylsulfide/sulfonyl-terminated amino-diol compounds for treatment of hypertensionSEARLE & CO·Filed 1992·Granted May 31, 1994·1 cites·25 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →